Literature DB >> 33483621

COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society.

Christopher E Clark1, Sinead T J McDonagh2, Richard J McManus3, Una Martin4.   

Abstract

Entities:  

Year:  2021        PMID： 33483621      PMCID： PMC7821986          DOI： 10.1038/s41371-020-00451-x

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  4 in total

1.  Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).

Authors:  Laine E Thomas; Robert O Bonow; Michael J Pencina
Journal:  JAMA Cardiol       Date:  2020-09-01       Impact factor: 14.676

2.  Clinical characteristics of fatal patients with severe acute respiratory syndrome in a medical center in Taipei.

Authors:  Wing-Wai Wong; Te-Li Chen; Su-Pen Yang; Fu-Der Wang; Nai-Cheng Cheng; Benjamin Ing-Tiau Kuo; Kwok-Woon Yu; Che-An Tsai; Yu-Shia Lin; I-Ru Lee; Chih-Yu Chi; Chorng-Jang Lai; Chung-Hsu Lai; Hsin-Pai Chen; Cheng-Yi Liu
Journal:  J Chin Med Assoc       Date:  2003-06       Impact factor: 2.743

3.  Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis.

Authors:  Giuseppe Lippi; Johnny Wong; Brandon M Henry
Journal:  Pol Arch Intern Med       Date:  2020-03-31

4.  Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.

Authors:  Muthiah Vaduganathan; Orly Vardeny; Thomas Michel; John J V McMurray; Marc A Pfeffer; Scott D Solomon
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245
  4 in total
  20 in total

1.  Estimating the Nosocomial Transmission Rate of COVID-19 in Orthopaedic Surgery Patients During the Peak of the Pandemic.

Authors:  Anna H Green; Julianne M Forlizzi; Joseph Boyle; Wilfrido J Castillo; Daniel Mascarenhas; Meizhen Yao; Geza Kiss; Carlos Sagebien
Journal:  Orthop Res Rev       Date:  2022-06-18

2.  Evaluating the role of transthoracic echocardiography in hospitalised patients with COVID-19 infection.

Authors:  Aswin Babu; Zhaoyi Meng; Nadia Eden; Daniel Lamb; Jan Nouza; Raghav Bhatia; Irina Chis Ster; Jonathan Bennett; Victor Voon
Journal:  Open Heart       Date:  2022-05

3.  Comparative characterisation of COVID-19 patients with hypertension comorbidity in Malawi: a 1:2 matched retrospective case-control study.

Authors:  Master R O Chisale; Billy W Nyambalo; Collins Mitambo; Pizga Kumwenda; Saul E Mwale; Balwani Chingatichifwe Mbakaya
Journal:  IJID Reg       Date:  2021-11-22

4.  Risk Perception and Knowledge, Attitudes, and Practices Against COVID-19 in a Hypertensive Population From a Semi-Urban City of Ecuador.

Authors:  Teresa Aumala; Maria Cardenas; Daniel Vergara; Monserrate Vasconez; Ivan Palacios; Enrique Terán
Journal:  Front Public Health       Date:  2021-12-14

5.  Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India.

Authors:  Nirav Nimavat; Shruti Singh; Pratibha Singh; Sunil Kumar Singh; Nishi Sinha
Journal:  Ann Med Surg (Lond)       Date:  2021-08-05

Review 6.  Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat.

Authors:  Rohit Sen; Devashish Sengupta; Avinaba Mukherjee
Journal:  Environ Sci Pollut Res Int       Date:  2021-12-02       Impact factor: 5.190

7.  Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.

Authors:  Miklós Fagyas; Viktor Bánhegyi; Zoltán Papp; Katalin Úri; Attila Enyedi; Erzsébet Lizanecz; Ivetta Siket Mányiné; Lilla Mártha; Gábor Áron Fülöp; Tamás Radovits; Miklós Pólos; Béla Merkely; Árpád Kovács; Zoltán Szilvássy; Zoltán Ungvári; István Édes; Zoltán Csanádi; Judit Boczán; István Takács; Gábor Szabó; József Balla; György Balla; Petar Seferovic; Attila Tóth
Journal:  Geroscience       Date:  2021-10-21       Impact factor: 7.713

8.  The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19.

Authors:  Ferhat Işık; Murat Çap; Abdurrahman Akyüz; Önder Bilge; Burhan Aslan; Ümit İnci; İlyas Kaya; Ercan Taştan; Metin Okşul; Neşe Kanbal Çap; Ali Karagöz; Erkan Baysal
Journal:  J Hum Hypertens       Date:  2021-08-05       Impact factor: 2.877

9.  Changes in the Prevalence of Metabolic Syndrome, Its Components, and Relevant Preventive Medication between 2011 and 2018 in the Northeast Hungarian Roma Population.

Authors:  Peter Piko; Judit Dioszegi; Zsigmond Kosa; Janos Sandor; Mariann Moizs; Roza Adany
Journal:  J Pers Med       Date:  2021-06-24

10.  Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations.

Authors:  Mohamad Saifudin Hakim; Hendra Wibawa; Ika Trisnawati; Endah Supriyati; Riat El Khair; Kristy Iskandar; Nungki Anggorowati; Edwin Widyanto Daniwijaya; Dwi Aris Agung Nugrahaningsih; Yunika Puspadewi; Susan Simanjaya; Dyah Ayu Puspitarani; Hana Fauzyyah Hanifin; Alvina Alexandra Setiawan; Irene Tania; Cita Shafira Amalia; I Putu Aditio Artayasa; Haries Rachman; Herdiyanto Mulyawan; Nur Rahmi Ananda; Eggi Arguni; Titik Nuryastuti; Tri Wibawa
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.